DCPH
Deciphera Pharmaceuticals, Inc.
$14.58
Earnings Summary
Revenue | $48.29Mn |
Net Profits | $-47.19Mn |
Net Profit Margins | -97.71% |
Highlights
Deciphera Pharmaceuticals, Inc.’s revenue jumped 32.88% since last year same period to $48.29Mn in the Q4 2023. On a quarterly growth basis, Deciphera Pharmaceuticals, Inc. has generated 11.5% jump in its revenue since last 3-months.
Deciphera Pharmaceuticals, Inc.’s net profit fell -2.73% since last year same period to $-47.19Mn in the Q4 2023. On a quarterly growth basis, Deciphera Pharmaceuticals, Inc. has generated 4.82% jump in its net profits since last 3-months.
Deciphera Pharmaceuticals, Inc.’s net profit margin jumped 22.69% since last year same period to -97.71% in the Q4 2023. On a quarterly growth basis, Deciphera Pharmaceuticals, Inc. has generated 14.64% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Deciphera Pharmaceuticals, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.55 |
EPS Estimate Current Year | -0.55 |
Highlights
Deciphera Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.55 - a 5.17% jump from last quarter’s estimates.
Deciphera Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -0.55.
Key Ratios
Key ratios of the Deciphera Pharmaceuticals, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.54 |
Highlights
Deciphera Pharmaceuticals, Inc.’s earning per share (EPS) jumped 10% since last year same period to -0.54 in the Q4 2023. This indicates that the Deciphera Pharmaceuticals, Inc. has generated 10% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-09 | -0.62 | -0.57 | 8.06% |
2023-05-03 | -0.59 | -0.6 | -1.69% |
2024-02-07 | -0.58 | -0.54 | 6.9% |
2023-10-30 | -0.61 | -0.58 | 4.92% |
₹0 US Stocks a/c Opening Fee